AGIOS PHARMACEUTICALS

Lobbying for AGIOS PHARMACEUTICALS · Pharmacy, Medicare/Medicaid, Health Issues

Filing 2nd Quarter - Amendment

2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $20,000.00 expenses · posted Jul 22, 2025

Lobbying activity 3

Health Issues

Sickle Cell policy Biotech innovation

Medicare/Medicaid

Medicaid reform

Pharmacy

Biotech innovation

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.